[ESC Guidelines on cardiovascular diseases and pregnancy-most important facts of the 2025 update] [0.03%]
[欧洲心脏病学会妊娠心血管疾病指南-2025年更新最重要的事实]
Ute Seeland
Ute Seeland
The 2025 European Society of Cardiology (ESC) Guidelines on cardiovascular disease in pregnancy represents the second revision of the guideline versions published in 2011 and 2018. The new version aims to incorporate the most up-to-date evi...
[ESC guidelines on dyslipidemia update 2025 : New recommendations for the practice] [0.03%]
[2025年欧洲动脉粥样硬化学会（EAS）/欧洲心脏学会（ESC）血脂异常管理指南更新要点与临床实践新推荐]
Anna Hohneck,Oliver Weingärtner
Anna Hohneck
The 2025 update of the European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines on dyslipidemia introduce important innovations based on new evidence. The risk assessment is now conducted using the systematic c...
Review
Herz. 2025 Dec 9. DOI:10.1007/s00059-025-05354-6 2025
Bleeding risk associated with the co-use of direct oral anticoagulants and non-dihydropyridine calcium channel blockers: a meta-analysis [0.03%]
直接口服抗凝药与非二氢吡啶类钙拮抗剂合用的出血风险：一项荟萃分析
Francinny Alves Kelly,Elisa Andrade de Faria,Clara Rocha Dantas et al.
Francinny Alves Kelly et al.
Background: Oral anticoagulation is a cornerstone of stroke prevention in patients with atrial fibrillation (AF) and elevated thromboembolic risk. However, evidence regarding the association between co-use of direct oral ...
[Cardiovascular imaging using cardiac computed tomography and cardiac magnetic resonance imaging] [0.03%]
[应用心脏CT和磁共振成像的心血管影像学]
Nadine Abanador-Kamper,Andreas A Giannopoulos,Miltiadis Georgiadis et al.
Nadine Abanador-Kamper et al.
Noninvasive cardiac imaging using cardiac computed tomography (CCT) and cardiac magnetic resonance imaging (CMRI) has become established as an indispensable diagnostic instrument in modern cardiology for the assessment of cardiovascular dis...
Thomas Kleemann,David Duncker
Thomas Kleemann
Editorial
Herz. 2025 Dec;50(6):405-406. DOI:10.1007/s00059-025-05346-6 2025
[ESC/EACTS guidelines 2025 on the treatment of valvular heart disease : New standards in diagnostics and treatment] [0.03%]
[2025年欧洲心脏病学学会/欧洲心胸外科协会瓣膜性心脏病治疗指南：诊断和治疗新标准]
Anna Juliane Buch,Mateo Marin-Cuartas,Michael A Borger et al.
Anna Juliane Buch et al.
The treatment of valvular heart disease plays an important role in cardiovascular medicine. The 2025 European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) guidelines for the management of valvular hea...
Retraction Note: Kolloidosmotischer Druck und extravaskuläres Lungenwasser nach extrakorporaler Zirkulation [0.03%]
撤稿说明：胶体渗透压和体外循环后的肺间质液异常
J Boldt,B von Bormann,D Kling et al.
J Boldt et al.
Retraction Note: Der neue Phosphodiesterasehemmer Enoximone: Einsatzmöglichkeiten im Rahmen herzchirurgischer Eingriffe [0.03%]
撤回 notice: 新型磷酸二酯酶抑制剂恩那西莫nesoximone：心脏手术中的应用机会
J Boldt,D Kling,E Schuhmann et al.
J Boldt et al.
Procedural hospital volume and outcome after transcatheter edge-to-edge mitral valve repair : Analysis of the German mandatory quality registry [0.03%]
德国资质登记系统对经导管二尖瓣缘对缘修复术量效关系的分析
Julinda Mehilli,Maike Bestehorn,Christian Perings et al.
Julinda Mehilli et al.
Background: Studies assessing transcatheter edge-to-edge mitral valve repair (M-TEER) suggest lower rates of in-hospital mortality (IHM) at high-volume hospitals, and guidelines recommend minimum caseloads to assure quali...
Suzanne de Waha,Mateo Marín-Cuartas,Madlen Uhlemann et al.
Suzanne de Waha et al.
Infective endocarditis is a rare disease with increasing incidence and high mortality. Due to its nonspecific symptoms, complex diagnostics, the prolonged treatment and poor prognosis, it represents a major clinical challenge. This review a...